Tumor-specific antigens in cutaneous T-cell lymphoma: Expression and sero-reactivity

Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of extra-nodal non-Hodgkin lymphomas with primary manifestation in the skin with poor treatment options in the advanced stages. As basis for future immune-therapeutic strategies we have investigated the possible expression of tumor-specific t...

Full description

Saved in:
Bibliographic Details
Main Authors: Eichmüller, Stefan B. (Author) , Usener, Dirk (Author) , Thiel, Daniela (Author) , Schadendorf, Dirk (Author)
Format: Article (Journal)
Language:English
Published: 16 January 2003
In: International journal of cancer
Year: 2003, Volume: 104, Issue: 4, Pages: 482-487
ISSN:1097-0215
DOI:https://doi.org/10.1002/ijc.10967
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1002/ijc.10967
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10967
Get full text
Author Notes:Stefan Eichmüller, Dirk Usener, Daniela Thiel and Dirk Schadendorf

MARC

LEADER 00000caa a2200000 c 4500
001 1739038606
003 DE-627
005 20230320133820.0
007 cr uuu---uuuuu
008 201118s2003 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.10967  |2 doi 
035 |a (DE-627)1739038606 
035 |a (DE-599)KXP1739038606 
035 |a (OCoLC)1341377814 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eichmüller, Stefan B.  |d 1960-  |e VerfasserIn  |0 (DE-588)1025289226  |0 (DE-627)721986951  |0 (DE-576)37016704X  |4 aut 
245 1 0 |a Tumor-specific antigens in cutaneous T-cell lymphoma  |b Expression and sero-reactivity  |c Stefan Eichmüller, Dirk Usener, Daniela Thiel and Dirk Schadendorf 
264 1 |c 16 January 2003 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.11.2020 
520 |a Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of extra-nodal non-Hodgkin lymphomas with primary manifestation in the skin with poor treatment options in the advanced stages. As basis for future immune-therapeutic strategies we have investigated the possible expression of tumor-specific targets in CTCL focusing mainly on so-called cancer-germline genes. cDNAs derived from 20 CTCL tissues and 4 CTCL cell lines were tested with 15 gene-specific and 4 gene family-specific primers by RT-PCR and confirmative Northern blotting. The most frequently detected mRNAs were LAGE-1 (55% with only partial coexpression of the splicing variants), cTAGE-1 (35%), MAGE-A9 (27%) and the GAGE-3-7 group (35%). Furthermore, we could detect NY-ESO-1 (21%) and a MAGE-A subgroup (15%), whereas sub-specification of the latter proved absence of MAGE-A1, -A2, -A3, -A6 and -A12. SCP-1 was found in only one specimen and a several antigens could not been detected in any tumor tissue or cell line (MAGE-B, GAGE-1,2,8 and all 4 RAGE genes). 90% of all CTCL samples were positive for at least 1 of the frequent mRNAs in RT-PCR (LAGE-1, NY-ESO-1, cTAGE-1, MAGE-A9, or GAGE-3to7). Using a secondary SEREX approach we could detect sero-reactivity in sera of CTCL patients against recombinant cTAGE-1 (10/29), GAGE (3/19), MAGE-A1 (1/18), -A3 (1/18), -A6 (2/18) and -A9 (4/18) protein, but not against LAGE-1a, MAGE-A4b or MAGE-A12 protein (n = 19). We conclude, that certain cancer-germline genes can be detected frequently in CTCL and are able to elicit a systemic immune response. These candidate genes might therefore be promising targets for immunotherapeutic interventions in CTCL. 
650 4 |a cancer-germline genes 
650 4 |a CTCL 
650 4 |a tumor antigens 
700 1 |a Usener, Dirk  |d 1972-  |e VerfasserIn  |0 (DE-588)124823378  |0 (DE-627)366751735  |0 (DE-576)294520791  |4 aut 
700 1 |a Thiel, Daniela  |e VerfasserIn  |0 (DE-588)1179489802  |0 (DE-627)1067390251  |0 (DE-576)518261352  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 104(2003), 4, Seite 482-487  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Tumor-specific antigens in cutaneous T-cell lymphoma Expression and sero-reactivity 
773 1 8 |g volume:104  |g year:2003  |g number:4  |g pages:482-487  |g extent:6  |a Tumor-specific antigens in cutaneous T-cell lymphoma Expression and sero-reactivity 
856 4 0 |u https://doi.org/https://doi.org/10.1002/ijc.10967  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10967  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201118 
993 |a Article 
994 |a 2003 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 4  |y j 
998 |g 1025289226  |a Eichmüller, Stefan B.  |m 1025289226:Eichmüller, Stefan B.  |d 140000  |e 140000PE1025289226  |k 0/140000/  |p 1  |x j 
999 |a KXP-PPN1739038606  |e 3806635811 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"16 January 2003"}],"note":["Gesehen am 18.11.2020"],"title":[{"title_sort":"Tumor-specific antigens in cutaneous T-cell lymphoma","subtitle":"Expression and sero-reactivity","title":"Tumor-specific antigens in cutaneous T-cell lymphoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Eichmüller, Stefan B.","family":"Eichmüller","given":"Stefan B.","role":"aut"},{"display":"Usener, Dirk","family":"Usener","given":"Dirk","role":"aut"},{"family":"Thiel","display":"Thiel, Daniela","given":"Daniela","role":"aut"},{"given":"Dirk","role":"aut","family":"Schadendorf","display":"Schadendorf, Dirk"}],"relHost":[{"disp":"Tumor-specific antigens in cutaneous T-cell lymphoma Expression and sero-reactivityInternational journal of cancer","corporate":[{"display":"International Union against Cancer","role":"isb"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"part":{"extent":"6","volume":"104","year":"2003","pages":"482-487","text":"104(2003), 4, Seite 482-487","issue":"4"},"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"origin":[{"dateIssuedKey":"1966","publisher":"Wiley-Liss","dateIssuedDisp":"1966-","publisherPlace":"Bognor Regis"}],"titleAlt":[{"title":"Predictive oncology"}],"title":[{"title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"269532781","pubHistory":["1.1966 -"],"id":{"doi":["10.1002/(ISSN)1097-0215"],"issn":["1097-0215"],"eki":["269532781"],"zdb":["1474822-8"]}}],"id":{"doi":["10.1002/ijc.10967"],"eki":["1739038606"]},"recId":"1739038606","name":{"displayForm":["Stefan Eichmüller, Dirk Usener, Daniela Thiel and Dirk Schadendorf"]},"physDesc":[{"extent":"6 S."}]} 
SRT |a EICHMUELLETUMORSPECI1620